Cefepime versus ceftriaxone for empiric treatment of hospitalized patients with community-acquired pneumonia

被引：1
|
作者：
Borja, J [1 ]
Jané, F [1 ]
机构：
[1] Hosp Santa Creu & St Pau, Dept Clin Pharmacol, Barcelona 08025, Spain
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1999年 / 43卷 / 02期
关键词：
D O I：
10.1128/AAC.43.2.436
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
下载
收藏
页码：436 / 436
页数：1
相关论文
共 50 条
  • [1] Cefepime versus ceftriaxone for empiric treatment of hospitalized patients with community-acquired pneumonia
    Zervos, M
    Nelson, M
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (04) : 729 - 733
  • [2] Effectiveness of ceftriaxone plus doxycycline in the treatment of patients hospitalized with community-acquired pneumonia.
    Flanders, A
    Dudas, V
    Kerr, K
    McCulloch, CE
    Gonzales, R
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2003, 18 : 224 - 224
  • [3] Effect of empiric regimen on outcomes in hospitalized patients with community-acquired pneumonia
    Brown, PD
    Trowbridge, J
    Artymowicz, R
    Lee, C
    Farber, M
    Kernan, W
    Beaulieu, J
    Goldman, MP
    Lewis, JS
    Ravikrishnan, K
    Lubowski, T
    CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) : 1110 - 1110
  • [4] Treatment of hospitalized patients with community-acquired pneumonia
    Leenders, ACAP
    CLINICAL INFECTIOUS DISEASES, 2006, 43 (01) : 109 - 110
  • [5] Empiric antimicrobial treatment of community-acquired pneumonia
    Kioumis, Ioannis P.
    PNEUMON, 2012, 25 : 43 - 46
  • [6] Ceftriaxone versus ceftriaxone plus a macrolide for community-acquired pneumonia in hospitalized patients with HIV/AIDS: a randomized controlled trial
    Figueiredo-Mello, C.
    Naucler, P.
    Negra, M. D.
    Levin, A. S.
    CLINICAL MICROBIOLOGY AND INFECTION, 2018, 24 (02) : 146 - 151
  • [7] Treatment for Hospitalized Patients With Severe Community-Acquired Pneumonia
    Pepper, Dominique J.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 313 (21): : 2184 - 2184
  • [8] Sequential intravenous/oral ciprofloxacin compared with parenteral ceftriaxone in the treatment of hospitalized patients with community-acquired pneumonia
    Johnson, RH
    Levine, S
    Traub, SL
    Echols, RM
    Haverstock, D
    Arnold, E
    Kowalsky, SF
    INFECTIOUS DISEASES IN CLINICAL PRACTICE, 1996, 5 (04) : 265 - 272
  • [9] Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired Pneumonia
    Marin-Corral, Judith
    Pascual-Guardia, Sergi
    Amati, Francesco
    Aliberti, Stefano
    Masclans, Joan R.
    Soni, Nilam
    Rodriguez, Alejandro
    Sibila, Oriol
    Sanz, Francisco
    Sotgiu, Giovanni
    Anzueto, Antonio
    Dimakou, Katerina
    Petrino, Roberta
    van de Garde, Ewoudt
    Restrepo, Marcos I.
    CHEST, 2021, 159 (01) : 58 - 72
  • [10] Aspiration risks factors, microbiology and empiric antibiotics for patients hospitalized with community-acquired pneumonia
    Marin Corral, Judith
    Pascual Guardia, Sergi
    Amati, Francesco
    Aliberti, Stefano
    Ramon Masclans, Joan
    Soni, Nilam
    Rodriguez, Alejandro
    Sbila, Oriol
    Sanz, Francisco
    Sotgiu, Giovanni
    Anzueto, Antonio
    Dimakou, Katerina
    Medenica, Miras
    Petrino, Roberta
    Van de Garde, Ewoudt
    Restrepo, Marcos, I
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
12345